{"id":914017,"date":"2025-11-26T08:10:00","date_gmt":"2025-11-26T13:10:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/"},"modified":"2025-11-26T08:10:00","modified_gmt":"2025-11-26T13:10:00","slug":"genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/","title":{"rendered":"Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference"},"content":{"rendered":"
\n

WESTLAKE VILLAGE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) — Genelux Corporation<\/a> (<\/a>NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief Financial Officer, will participate in a fireside chat at the Piper Sandler 37th<\/sup> Annual Healthcare Conference on Wednesday, December 3, 2025 at 12:00 p.m. ET in New York, NY.<\/p>\n

A live webcast of the fireside chat can be found here<\/a>. Following the live webcast, an archived replay will be available on the Company\u2019s website https:\/\/investors.genelux.com\/<\/a>.<\/p>\n

\n About Genelux Corporation<\/strong>\n <\/p>\n

Genelux\u00a0is a late clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic immunotherapies for patients suffering from aggressive and\/or difficult-to-treat solid tumor types. Olvi-Vec currently is being evaluated in two\u00a0U.S.-based clinical trials: OnPrime\/GOG-3076, a multi-center, randomized, open-label Phase 3 registrational trial evaluating the efficacy and safety of Olvi-Vec in combination platinum-doublet + bevacizumab compared with physician’s choice of chemotherapy and bevacizumab in patients with platinum-resistant\/refractory ovarian cancer; and, VIRO-25, a multi-center, randomized, open-label Phase 2 trial evaluating the efficacy and safety of Olvi-Vec & platinum-doublet + physician’s choice of immune checkpoint inhibitor compared to docetaxel in non-small-cell lung cancer. Additionally, Olvi-Vec currently is being evaluated for dose selection in Olvi-Vec-SCLC-202, a\u00a0China-based, multi-center, open label Phase 1b trial evaluating the efficacy and safety of Olvi-Vec & platinum-doublet in recurrent small-cell lung cancer. The core of\u00a0Genelux’s\u00a0discovery and development efforts revolves around its proprietary CHOICE\u2122 platform from which the Company has developed an extensive library of isolated and engineered oncolytic vaccinia virus immunotherapeutic product candidates, including Olvi-Vec. For more information, please visit\u00a0www.genelux.com<\/a>\u00a0and follow us on X\u00a0@Genelux_Corp<\/a>\u00a0and on\u00a0LinkedIn<\/a>.<\/p>\n

\n Investor Contact<\/strong>\n <\/p>\n

Austin Murtagh
Precision AQ
austin.murtagh@precisionaq.com<\/a><\/p>\n

\n Media Contact<\/strong>\n <\/p>\n

Ashley Murphy
Precision AQ
ashley.murphy@precisionaq.com<\/a><\/p>\n

Source: Genelux Corporation<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

WESTLAKE VILLAGE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief Financial Officer, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 12:00 p.m. ET in New York, NY. A live webcast of the fireside chat can be found here. Following the live webcast, an archived replay will be available on the Company\u2019s website https:\/\/investors.genelux.com\/. About Genelux Corporation Genelux\u00a0is a late clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic immunotherapies for patients suffering from aggressive and\/or difficult-to-treat solid tumor types. Olvi-Vec currently is … <\/p>\n

Continue reading “Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-914017","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGenelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WESTLAKE VILLAGE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief Financial Officer, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 12:00 p.m. ET in New York, NY. A live webcast of the fireside chat can be found here. Following the live webcast, an archived replay will be available on the Company\u2019s website https:\/\/investors.genelux.com\/. About Genelux Corporation Genelux\u00a0is a late clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic immunotherapies for patients suffering from aggressive and\/or difficult-to-treat solid tumor types. Olvi-Vec currently is … Continue reading "Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-26T13:10:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjQ0MyM3MjkzMjU5IzIyNDkwNTQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference\",\"datePublished\":\"2025-11-26T13:10:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\\\/\"},\"wordCount\":318,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjQ0MyM3MjkzMjU5IzIyNDkwNTQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\\\/\",\"name\":\"Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjQ0MyM3MjkzMjU5IzIyNDkwNTQ=\",\"datePublished\":\"2025-11-26T13:10:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjQ0MyM3MjkzMjU5IzIyNDkwNTQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjQ0MyM3MjkzMjU5IzIyNDkwNTQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk","og_description":"WESTLAKE VILLAGE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board and Matt Pulisic, Chief Financial Officer, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 12:00 p.m. ET in New York, NY. A live webcast of the fireside chat can be found here. Following the live webcast, an archived replay will be available on the Company\u2019s website https:\/\/investors.genelux.com\/. About Genelux Corporation Genelux\u00a0is a late clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic immunotherapies for patients suffering from aggressive and\/or difficult-to-treat solid tumor types. Olvi-Vec currently is … Continue reading \"Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-26T13:10:00+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjQ0MyM3MjkzMjU5IzIyNDkwNTQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference","datePublished":"2025-11-26T13:10:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/"},"wordCount":318,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjQ0MyM3MjkzMjU5IzIyNDkwNTQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/","name":"Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjQ0MyM3MjkzMjU5IzIyNDkwNTQ=","datePublished":"2025-11-26T13:10:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjQ0MyM3MjkzMjU5IzIyNDkwNTQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjQ0MyM3MjkzMjU5IzIyNDkwNTQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-piper-sandler-37th-annual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/914017","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=914017"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/914017\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=914017"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=914017"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=914017"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}